Core Viewpoint - Qingdao Senqilin Tire Co., Ltd. has adjusted the exercise price of its 2022 stock option incentive plan due to a cash dividend distribution, which will not materially affect the company's financial status or operating results [1]. Group 1: Stock Performance - As of January 12, 2026, Senqilin's stock closed at 21.25 yuan, down 0.09% from the previous trading day, with a total market capitalization of 22.015 billion yuan [1]. - The stock opened at 21.18 yuan, reached a high of 21.29 yuan, and a low of 20.90 yuan, with a trading volume of 282 million yuan and a turnover rate of 1.87% [1]. Group 2: Stock Option Adjustment - The company's board of directors approved the adjustment of the exercise price from 16.47 yuan to 16.17 yuan per share following a cash dividend distribution of 3.0 yuan per 10 shares [1]. - The adjustment has undergone necessary approval procedures and complies with relevant laws and regulations, as well as the company's incentive plan [1].

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或者重大 遗漏。 重要内容提示： 1.股票期权授予登记完成日：2026年1月9日 2.股票期权登记数量：10,403,050份 3.期权简称：北方JLC6 4.期权代码：037949 根据中国证监会《上市公司股权激励管理办法》、深圳证券交易所、中国证券登记结算有限责任公司深 圳分公司有关规定，北方华创科技集团股份有限公司（简称"公司"或"本公司"）完成了2025年股票期权 激励计划（简称"2025年股票期权激励计划"）股票期权授予登记工作。期权简称：北方JLC6，期权代 码：037949 ，现将有关事项公告如下： 一、2025年股票期权激励计划的决策程序和批准情况 1．2025年11月21日，公司第八届董事会第二十九次会议审议通过了《关于〈北方华创科技集团股份有 限公司2025年股票期权激励计划（草案）〉及其摘要的议案》《关于〈北方华创科技集团股份有限公司 2025年股票期权激励计划实施考核管理办法〉的议案》《关于提请股东大会授权董事会办理股权激励相 关事宜的议案》和《关于召开2 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 ● 本次股票上市流通日期为2026年1月15日。 根据中国证券监督管理委员会、上海证券交易所、中国证券登记结算有限责任公司上海分公司相关业务 规定，苏州伟创电气科技股份有限公司（以下简称公司）于近日收到中国证券登记结算有限责任公司上 海分公司出具的《证券变更登记证明》，公司完成了2024年股票期权激励计划（以下简称本次激励计 划）第一个行权期第二批次行权的股份登记工作。现将有关情况公告如下： 一、本次激励计划行权的决策程序和相关信息披露 1、2024年4月24日，公司召开第二届董事会第二十三次会议，会议审议通过了《关于公司〈2024年股票 期权激励计划（草案）〉及其摘要的议案》《关于公司〈2024年股票期权激励计划实施考核管理办法〉 的议案》以及《关于提请股东大会授权董事会办理2024年股票期权激励计划相关事宜的议案》等议案。 公司独立董事就本激励计划相关议案发表了独立意见。 同日，公司召开第二届监事会第十九次会议，审议通过了 ...

Core Viewpoint - The company has established a comprehensive incentive mechanism, utilizing a variety of methods to motivate core personnel and attract more talented individuals, with the stock option incentive plan being one of the diverse incentive methods [1] Summary by Relevant Sections - Stock Option Plans - The exercise price for the stock option incentive plan established in 2021 was set at 21.00 yuan per share, while the 2022 plan's exercise price was set at 20.00 yuan per share, both of which are higher than the company's current stock price [1] - The stock option incentive plans are based on a self-exercise model, allowing the incentive recipients to decide on exercising options based on the exercise price, stock price, and their own financial situation [1] - Incentive Mechanism - The company has developed a well-rounded incentive mechanism that includes various incentive methods to motivate key personnel and attract more outstanding talent [1]

Core Viewpoint - The announcement details the stock option incentive plan of Fujian Tianma Technology Group Co., Ltd., highlighting the execution of stock options and the resulting changes in shareholding structure. Group 1: Stock Option Exercise Details - The number of stock options available for exercise in the first exercise period of the 2024 stock option incentive plan is 3.8632 million, with the actual exercise period from July 9, 2025, to July 8, 2026. In Q4 2025, 2,579,509 shares were exercised, accounting for 66.77% of the total options available for exercise [2] - As of the end of Q4 2025, a cumulative total of 3,387,531 shares have been exercised and registered, representing 87.69% of the total options available for exercise [2] Group 2: Decision-Making and Disclosure Process - On May 17, 2024, the company held board and supervisory meetings to approve the stock option incentive plan, with independent directors soliciting votes from shareholders and the supervisory board providing verification opinions [3] - The list of proposed incentive recipients was publicly disclosed internally from May 18 to May 27, 2024, with no objections received by the supervisory board [3] Group 3: Stock Option Grant and Registration - On July 9, 2024, the company approved the adjustment of the incentive recipient list and the grant of stock options, with a total of 10.12 million options granted at a price of 13.60 yuan per option [6] - The registration of the stock options was completed on July 26, 2024, with 140 recipients involved [6] Group 4: Impact on Share Capital and Financials - By the end of Q4 2025, the total number of shares registered through the incentive plan was 3,387,531, raising approximately 45.93 million yuan, which will be used to supplement the company's working capital [14] - The exercise of these options is not expected to have a significant impact on the company's financial condition or operating results [14]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要提示内容： 1、本次行权股票数量：2025年第四季度，浙江康恩贝制药股份有限公司（以下简称"公司""本公司"） 2022年股票期权激励计划（以下简称"本次激励计划"）激励对象行权且完成股份过户登记的股票数量合 计为963.8570万股。 2、本次行权股票上市流通时间：本次激励计划采用自主行权方式行权，激励对象（除公司董事、高级 管理人员外）行权所得股票于行权日（T日）后的第二个交易日（T+2）日可上市交易。 2025年第四季度，公司本次激励计划激励对象行权且完成股份过户登记的股票数量合计为963.8570万 股。有关情况公告如下： 一、本次激励计划已履行的决策程序及相关信息披露 （一）2022年9月15日，公司十届董事会第二十二次（临时）会议和十届监事会第十三次（临时）会议 分别审议通过了《关于〈浙江康恩贝制药股份有限公司2022年股票期权激励计划（草案）〉及摘要的议 案》及其他相关议案，公司独立董事、监事会、律师均发表了相关 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：601607 证券简称：上海医药 编号：临2026-001 上海医药集团股份有限公司 关于2019年A股股票期权激励计划预留股票期权第三个行权期2025年第四季度自主行权结果公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ● 上海医药集团股份有限公司（以下简称"上海医药"或"公司"）2019年A股股票期权激励计划（"本次股 权激励计划"）预留股票期权第三个行权期可行权的股票期权数量680,000份，行权期自2025年2月8日起 至2026年2月7日止。 ● 本次行权股票数量：2025年第四季度，公司预留股票期权第三个行权期激励对象未行权。 一、本次股权激励计划已履行的相关审批程序 1、2019年9月30日，公司召开第七届董事会第五次会议及第七届监事会第三次会议，审议通过了《关于 2019年股票期权激励计划（草案）及其摘要的议案》（以下简称"《股票期权激励计划（草案）》"）、 《关于2019年股票期权激励计划实施考核管理办法的议案》（以下简称 ...

Core Viewpoint - The announcement details the results of the stock option incentive plan for the fourth quarter of 2025, highlighting the number of stock options exercised and the overall impact on the company's share structure and financials. Group 1: Stock Option Exercise Results - The number of stock options exercised in the second exercise period of the 2023 stock option incentive plan is 6.2832 million, with a total of 4,396,090 shares exercised by the end of 2025, accounting for 69.97% of the total exercisable options [1][12][15] - From October 1, 2025, to December 31, 2025, a total of 159,860 shares were exercised and registered [1][12] Group 2: Stock Option Plan Overview - The 2023 stock option incentive plan was approved by the board and shareholders, with 2.247 million options granted to 350 eligible participants on April 17, 2023 [2][4] - The plan includes provisions for adjustments to the exercise price, which has been modified multiple times, with the latest adjustment setting the price at 27.269 yuan per share [5][11] Group 3: Financial Impact and Fund Utilization - The funds raised from the stock option exercise amount to 4,359,222.34 yuan, with a total of 119,876,978.21 yuan raised by the end of 2025 [14][15] - The raised funds will be used to supplement the company's cash flow, and the exercise does not significantly impact the company's financial condition or operating results [15]

Core Viewpoint - The announcement details the results of the stock option exercise for the third exercise period of the 2021 stock option and restricted stock incentive plan of Qingdao Hairong Commercial Cold Chain Co., Ltd, indicating no shares were exercised during the specified period [2][12]. Group 1: Stock Option Exercise Details - The number of stock options available for exercise in the third period is 64,175, with an exercise window from December 20, 2024, to December 19, 2025 [2][12]. - No shares were exercised or transferred as of December 31, 2025, representing 0.00% of the total options available for this period [2][12]. - The stocks obtained through the exercise will be listed for trading on the second trading day after the exercise date [2][14]. Group 2: Decision-Making Process and Disclosure - The decision-making process for the stock option plan was approved by the board and supervisory board in meetings held on April 22, 2021, with independent directors providing their consent [3][5]. - The company conducted an internal announcement of the incentive recipients from April 26 to May 10, 2021, with no objections received [4]. - The annual shareholders' meeting on May 24, 2021, approved the incentive plan and related matters [4][5]. Group 3: Historical Context and Adjustments - The company has made several adjustments to the incentive plan since its inception, including the approval of stock option grants and the cancellation of certain options in subsequent board meetings [6][8][10]. - As of October 26, 2023, the board approved the conditions for the second exercise period and the lifting of restrictions on the corresponding restricted stocks [8][10]. - The company has consistently fulfilled its disclosure obligations regarding the incentive plan adjustments and stock option exercises [11].

Core Viewpoint - The announcement details the stock option incentive plan of Guangzhou Fangbang Electronics Co., Ltd., highlighting the execution results and share changes related to the plan for the fourth quarter of 2025. Group 1: Stock Option Exercise Details - The second exercise period of the stock option incentive plan allows for 640,000 options, with 417,000 shares exercised by the end of 2025, representing 65.16% of the available options [2][9] - The first exercise period of the reserved stock options allows for 223,500 options, with 100,500 shares exercised by the end of 2025, representing 44.97% of the available options [2][13] - The total number of shares listed for trading after the exercise in the fourth quarter of 2025 is 1,000 shares, which are all unrestricted circulating shares [14] Group 2: Decision-Making and Disclosure Process - The decision-making process for the stock option plan involved multiple board meetings and approvals, including independent opinions from directors and the supervisory board [4][6] - The plan was publicly announced and no objections were raised during the public notice period [5] - The stock options were granted to 68 incentive targets at an exercise price of 34 yuan per option [6] Group 3: Financial Impact and Fund Utilization - The funds raised from the exercise of stock options in the fourth quarter amount to 33,627 yuan, which will be used to supplement the company's working capital [18] - The stock option exercise is not expected to have a significant impact on the company's financial status or operating results [19]